RSV vaccine recommendations for immunocompromised patients
Current recommendations
All immunocompromised individuals aged ≥18 years should receive the RSV vaccine.
There was no evidence available for immunocompromised children and adolescents. These patients should discuss the risks and benefits of age-appropriate RSV vaccination with their clinician.
Full Evidence Review / Vaccine Integrity Project Data Tool / Infectious Diseases Society of America Recommendation
Source: Infectious Diseases Society of America
Resources for your patients
Resources for physicians
Current recommendations
All immunocompromised individuals aged 18 and older should receive the RSV vaccine.
There was no evidence available for immunocompromised children and adolescents. These patients should discuss the risks and benefits of RSV vaccination with their clinician.
Full Evidence Review / Vaccine Integrity Project Data Tool / Infectious Diseases Society of America Recommendation
Source: Infectious Diseases Society of America